AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit Read more
Daiichi Sankyo Announces Decision to Develop Vaccine in Japan for Novel Corona Virus Infection (COVID-19) Read more
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment Read more
EIB to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development Read more
Grifols starts production of its hyperimmune immunoglobulin as a potential passive immune therapy against COVID-19 Read more
Takeda to Divest OTC and Select Non-core Assets in Asia Pacific to Celltrion for up to $278 Million USD Read more